"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (PURR-go-lide MEH-sih-LATE) |
| Permax |
| Class: Antiparkinson |
Action Directly stimulates postsynaptic dopamine receptors in nigrostriatal system.
Indications Adjunctive treatment to levodopa-carbidopa in management of Parkinson’s disease.
Contraindications Hypersensitivity to ergot derivatives.
Administer in divided doses tid. ADULTS: PO 0.05 mg/day first 2 days. Gradually increase dose by 0.1 to 0.15 mg/day q 3 days over next 12 days. Dose may then be increased by 0.25 mg/day q 3 days until optimum therapeutic dosage is achieved (mean therapeutic dose is 3 mg/day; maximum 5 mg/day). During titration cautiously decrease levodopa-carbidopa (average daily concurrent dose is 650 mg/day of levodopa).
Dopamine antagonists (eg, butyrophenones, metoclopramide, neuroleptics, phenothiazines, thioxanthenes): May diminish effectiveness of pergolide.
Lab Test Interferences None well documented.
CV: Orthostatic hypotension; vasodilation; palpitations; hypotension; syncope; hypertension; arrhythmia; MI. CNS: Dyskinesia; dizziness; hallucinations; dystonia; confusion; somnolence; insomnia; anxiety; personality disorder; psychosis; extrapyramidal syndrome; incoordination; akinesia; hypertonia; neuralgia. DERM: Rash; sweating. EENT: Abnormal vision; diplopia; glaucoma; eye hemorrhage; photophobia; visual field defect; taste perversion. GI: Nausea; constipation; diarrhea; dyspepsia; anorexia; dry mouth; vomiting. GU: Hematuria. RESP: Rhinitis; shortness of breath; epistaxis; hiccoughs. OTHER: Pains; accidental injury; flu syndrome; chills; peripheral edema; facial edema; edema; weight gain; anemia; bursitis; myalgia; twitching.
Pregnancy: Category B. Lactation: Unknown. Children: Safety and efficacy not established. Carcinogenesis: Uterine neoplasia has been observed with high doses of pergolide in animal models and was probably a result of prolactin inhibition. Cardiac arrhythmias: Exercise caution in patients with arrhythmias because of possible atrial premature contractions and sinus tachycardia. Hallucinosis: Hallucinations may occur in some patients. Symptomatic hypotension: Either symptomatic or orthostatic hypotension may occur, especially during initial treatment. With gradual titration, tolerance to hypotension usually develops.
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 1% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply